FDA NDC Directory · JSON-LD · Markdown

GRAFAPEX

NDC 59137-335 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nametreosulfan
Labeler / ManufacturerMedexus Pharma, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA214759
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsTREOSULFAN (1000 mg/g)
Marketing started20250128
Package count1

External sources

Source: openFDA. Public-domain (CC0).